County
Craven, Jones, Pamlico Counties EMS
Craven, Jones, Pamlico Counties EMS (NC) carries 65 drugs across 180 dose entries in its current published protocol, effective 2026-06-08.
Drugs and doses65
Acetaminophen
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Fever | adult | 1 g | IV/IO | not captured | standing | page 24 |
| Fever | adult | 325–1000 mg | PO | not captured | standing | page 24 |
| Fever | peds | 15 mg/kg | PO | not captured | standing | page 24 |
| Fever | peds | 15 mg/kg | IV/IO | not captured | standing | page 24 |
| Mild to moderate pain | adult | 1 g | IV/IO | not captured | standing | page 25 |
| Mild to moderate pain | adult | 325–1000 mg | PO | not captured | standing | page 25 |
| Mild to moderate pain | peds | 15 mg/kg | PO | not captured | standing | page 25 |
| Mild to moderate pain | peds | 15 mg/kg | IV/IO | not captured | standing | page 25 |
Adenosine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Narrow-complex tachycardia | adult | 12 mg | IV/IO | not captured | standing | page 79 |
| Narrow-complex tachycardia | peds | 0.1 mg/kg | IV/IO | not captured | standing | page 79 |
Albuterol
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Crush injury | adult | 2.5–5 mg | NEB | not captured | standing | page 123 |
| Respiratory distress | adult | 2.5–5 mg | NEB | not captured | standing | page 52 |
| Respiratory distress | peds | 1.25–2.5 mg | NEB | not captured | standing | page 52 |
Alteplase
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Stroke | adult | 0.9 mg/kg | IV | not captured | standing | page 114 |
Amiodarone
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Wide-complex tachycardia | adult | 150 mg | IV/IO | not captured | standing | page 81 |
| Wide-complex tachycardia | peds | 5 mg/kg | IV/IO | not captured | standing | page 81 |
| VF / pulseless VT | adult | 300 mg | IV/IO | not captured | standing | page 85 |
| VF / pulseless VT | peds | 5 mg/kg | IV/IO | not captured | standing | page 85 |
Aspirin
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| ACS / chest pain | adult | 325 mg | PO | not captured | standing | page 75 |
Atropine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Bradycardia | adult | 1 mg | IV/IO | not captured | standing | page 71 |
| Bradycardia | peds | 0.02 mg/kg | IV/IO | not captured | standing | page 71 |
| Nerve agent exposure | adult | 2 mg | IV/IO/IM | not captured | standing | page 181 |
| Nerve agent exposure | peds | Variable | IV/IO/IM | not captured | standing | page 181 |
Calcium Chloride
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Beta-blocker / calcium-channel-blocker overdose | adult | 1 g | IV/IO | not captured | standing | page 123 |
| Beta-blocker / calcium-channel-blocker overdose | peds | 20 mg/kg | IV/IO | not captured | standing | page 123 |
| Hyperkalemia | adult | 1 g | IV/IO | not captured | standing | page 123 |
| Hyperkalemia | peds | 20 mg/kg | IV/IO | not captured | standing | page 123 |
| Other | adult | 1 g | IV/IO | not captured | standing | page 112 |
Calcium Gluconate
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Beta-blocker / calcium-channel-blocker overdose | adult | 2 g | IV/IO | not captured | standing | page 179 |
| Beta-blocker / calcium-channel-blocker overdose | peds | 20 mg/kg | IV/IO | not captured | standing | page 179 |
| Hyperkalemia | adult | 2 g | IV/IO | not captured | standing | page 109 |
| Hyperkalemia | peds | 20 mg/kg | IV/IO | not captured | standing | page 109 |
| Other | adult | 2 g | IV/IO | not captured | standing | page 183 |
Casirivimab
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 600 mg | IV | not captured | standing | page 203 |
| Other | adult | 600 mg | SQ | not captured | standing | page 203 |
Cefepime
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Sepsis | adult | 2 g | IV | not captured | standing | page 34 |
Ceftriaxone
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Sepsis | adult | 1 g | IV/IO | not captured | standing | page 33 |
| Sepsis | peds | 50 mg/kg | IV/IO | not captured | standing | page 33 |
| Trauma / hemorrhage | adult | 1 g | IV/IO | not captured | standing | page 125 |
| Trauma / hemorrhage | peds | 50 mg/kg | IV/IO | not captured | standing | page 125 |
Dexamethasone
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Allergic reaction | adult | 10 mg | IV/IO/IM | not captured | standing | page 105 |
| Allergic reaction | peds | 0.5 mg/kg | IV/IO/IM | not captured | standing | page 105 |
| Respiratory distress | adult | 10 mg | IV/IO/IM | not captured | standing | page 52 |
| Respiratory distress | peds | 0.5 mg/kg | IV/IO/IM | not captured | standing | page 52 |
Dextrose
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Hypoglycemia | adult | 125 mL | IV/IO | not captured | standing | page 107 |
| Hypoglycemia | peds | 5 mL/kg | IV/IO | not captured | standing | page 107 |
Diazepam
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Seizure | adult | 5 mg | IV/IO | not captured | standing | page 30 |
| Seizure | peds | 0.1–0.3 mg/kg | IV/IO | not captured | standing | page 30 |
| Seizure | peds | 0.5 mg/kg | PR | not captured | standing | page 30 |
Diltiazem
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Narrow-complex tachycardia | adult | 0.25 mg/kg | IV/IO | not captured | standing | page 79 |
Diphenhydramine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Agitation | adult | 50 mg | PO | not captured | standing | page 40 |
| Allergic reaction | adult | 25–50 mg | PO | not captured | standing | page 105 |
| Allergic reaction | adult | 25–50 mg | IV/IO/IM | not captured | standing | page 105 |
| Allergic reaction | peds | 1 mg/kg | PO | not captured | standing | page 105 |
| Allergic reaction | peds | 1 mg/kg | IV/IO/IM | not captured | standing | page 105 |
| Dystonic reaction | adult | 25–50 mg | IV/IO/IM | not captured | standing | page 12 |
Droperidol
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Nausea / vomiting | adult | 1.25 mg | IV | not captured | standing | page 12 |
Epinephrine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Allergic reaction | adult | 0.3–0.5 mg | IM | not captured | standing | page 105 |
| Allergic reaction | adult | 0.5 mg | IV/IO | not captured | standing | page 105 |
| Allergic reaction | peds | 0.15 mg | IM | not captured | standing | page 105 |
| Allergic reaction | peds | 0.15 mg | IV/IO | not captured | standing | page 105 |
| Bradycardia | adult | 1–10 mcg | IV/IO | not captured | standing | page 71 |
| Cardiac arrest | adult | 1 mg | IV/IO | not captured | standing | page 69 |
| Cardiac arrest | peds | 0.01 mg/kg | IV/IO | not captured | standing | page 69 |
| Respiratory distress | adult | 0.3 mg | IM | not captured | standing | page 52 |
| Respiratory distress | peds | 0.01 mg/kg | IM | not captured | standing | page 52 |
Esmolol
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Wide-complex tachycardia | adult | 0.5 mg/kg | IV/IO | not captured | standing | page 85 |
| VF / pulseless VT | adult | 0.5 mg/kg | IV/IO | not captured | standing | page 85 |
Etomidate
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| RSI induction | adult | 0.3 mg/kg | IV/IO | not captured | standing | page 50 |
| RSI induction | peds | 0.3 mg/kg | IV/IO | not captured | standing | page 50 |
Fentanyl
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Mild to moderate pain | adult | 50–100 mcg | IV/IO/IM/IN | not captured | standing | page 25 |
| Mild to moderate pain | peds | 1 mcg/kg | IV/IO/IM/IN | not captured | standing | page 25 |
Furosemide
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| CHF / pulmonary edema | adult | 40 mg | IV | not captured | standing | page 77 |
Glucagon
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Beta-blocker / calcium-channel-blocker overdose | adult | 2–4 mg | IV/IO/IM | not captured | standing | page 179 |
| Beta-blocker / calcium-channel-blocker overdose | adult | 2–4 mg | IV/IO/IM | not captured | standing | page 179 |
| Beta-blocker / calcium-channel-blocker overdose | peds | 0.1 mg/kg | IV/IO/IM | not captured | standing | page 179 |
| Beta-blocker / calcium-channel-blocker overdose | peds | 0.1 mg/kg | IV/IO/IM | not captured | standing | page 179 |
| Hypoglycemia | adult | 1–2 mg | IM | not captured | standing | page 107 |
| Hypoglycemia | peds | 0.1 mg/kg | IM | not captured | standing | page 107 |
Haloperidol
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Agitation | adult | 5 mg | PO | not captured | standing | page 40 |
| Agitation | adult | 5 mg | IM | not captured | standing | page 40 |
| Hyperactive delirium | adult | 5 mg | IM | not captured | standing | page 41 |
Heparin
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| STEMI | adult | 50 unit/kg | IV | not captured | standing | page 75 |
Hydrocortisone
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Adrenal crisis | adult | 100 mg | IV/IO/IM | not captured | standing | page 113 |
| Adrenal crisis | peds | 2 mg/kg | IV/IO/IM | not captured | standing | page 113 |
Hydromorphone
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Mild to moderate pain | adult | 0.5 mg | IV/IO/IM | not captured | standing | page 26 |
| Mild to moderate pain | adult | 1 mg | IV/IO | not captured | standing | page 61 |
| Mild to moderate pain | peds | 0.02 mg/kg | IV/IO | not captured | standing | page 61 |
Hydroxocobalamin
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Cyanide poisoning | adult | 70 mg/kg | IV/IO | not captured | standing | page 170 |
| Cyanide poisoning | peds | 70 mg/kg | IV/IO | not captured | standing | page 170 |
Ibuprofen
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Fever | adult | 400–600 mg | PO | not captured | standing | page 24 |
| Fever | peds | 10 mg/kg | PO | not captured | standing | page 24 |
| Mild to moderate pain | adult | 400–600 mg | PO | not captured | standing | page 25 |
| Mild to moderate pain | peds | 10 mg/kg | PO | not captured | standing | page 25 |
Imdevimab
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 600 mg | IV | not captured | standing | page 203 |
| Other | adult | 600 mg | SQ | not captured | standing | page 203 |
Ipratropium
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Respiratory distress | adult | 0.5 mg | NEB | not captured | standing | page 52 |
| Respiratory distress | peds | 0.5 mg | NEB | not captured | standing | page 52 |
Ketamine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Hyperactive delirium | adult | 4 mg/kg | IM | not captured | standing | page 41 |
| Hyperactive delirium | peds | 2 mg/kg | IM | not captured | standing | page 41 |
| Mild to moderate pain | adult | 0.3 mg/kg | IV/IO | not captured | standing | page 25 |
| Seizure | adult | 1 mg/kg | IV/IO | not captured | standing | page 29 |
| Seizure | peds | 1 mg/kg | IV/IO | not captured | standing | page 29 |
Ketorolac
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Mild to moderate pain | adult | 15 mg | IV/IO | not captured | standing | page 25 |
| Mild to moderate pain | adult | 30 mg | IM | not captured | standing | page 25 |
| Mild to moderate pain | peds | 0.5 mg/kg | IV/IO | not captured | standing | page 25 |
| Mild to moderate pain | peds | 0.5 mg/kg | IM | not captured | standing | page 25 |
Labetalol
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 10 mg | IV/IO | not captured | standing | page 114 |
Levetiracetam
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Seizure | adult | 1 g | IV/IO | not captured | standing | page 29 |
| Seizure | peds | 15 mg/kg | IV/IO | not captured | standing | page 29 |
Lidocaine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Wide-complex tachycardia | adult | 1–1.5 mg/kg | IV/IO | not captured | standing | page 81 |
| VF / pulseless VT | adult | 1.5 mg/kg | IV/IO | not captured | standing | page 85 |
Lorazepam
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Agitation | adult | 2 mg | PO | not captured | standing | page 40 |
| Seizure | adult | 1–2 mg | IV | not captured | standing | page 30 |
Magnesium Sulfate
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Asthma / bronchospasm | adult | 2 g | IV/IO | not captured | standing | page 52 |
| Seizure | adult | 2 g | IV/IO | not captured | standing | page 30 |
| Wide-complex tachycardia | adult | 2 g | IV/IO | not captured | standing | page 83 |
| Wide-complex tachycardia | peds | 2 g | IV/IO | not captured | standing | page 83 |
Methylprednisolone
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Adrenal crisis | adult | 125 mg | IV/IO/IM | not captured | standing | page 113 |
| Adrenal crisis | peds | 2 mg/kg | IV/IO/IM | not captured | standing | page 113 |
| Other | adult | 125 mg | IV/IO | not captured | standing | page 187 |
Metoclopramide
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Nausea / vomiting | adult | 5 mg | IV/IO/IM | not captured | standing | page 12 |
Metoprolol
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Narrow-complex tachycardia | adult | 5 mg | IV/IO | not captured | standing | page 79 |
Midazolam
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Agitation | adult | 2.5 mg | IN | not captured | standing | page 40 |
| Agitation | adult | 2.5 mg | IV/IO/IN | not captured | standing | page 40 |
| Agitation | adult | 5 mg | IM | not captured | standing | page 40 |
| Agitation | peds | 0.1–0.2 mg/kg | IV/IO/IN | not captured | standing | page 40 |
| Agitation | peds | 0.1–0.2 mg/kg | IM | not captured | standing | page 40 |
| Agitation | peds | 2.5 mg | IN | not captured | standing | page 40 |
| Hyperactive delirium | adult | 10 mg | IM | not captured | standing | page 41 |
| Hyperactive delirium | peds | 0.1–0.2 mg/kg | IM | not captured | standing | page 41 |
| Mild to moderate pain | adult | 2–2.5 mg | IV/IO/IN | not captured | standing | page 60 |
| Mild to moderate pain | peds | 0.1–0.2 mg/kg | IV/IO/IN | not captured | standing | page 60 |
| Seizure | adult | 2–2.5 mg | IV/IO | not captured | standing | page 29 |
| Seizure | adult | 5–10 mg | IM/IN | not captured | standing | page 29 |
| Seizure | peds | 0.2 mg/kg | IV/IO | not captured | standing | page 29 |
| Seizure | peds | 0.2 mg/kg | IM/IN | not captured | standing | page 29 |
Morphine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Mild to moderate pain | adult | 2–4 mg | IV/IO/IM | not captured | standing | page 25 |
Naloxone
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Opioid overdose | adult | 0.4–2 mg | IM/IN | not captured | standing | page 73 |
| Opioid overdose | adult | 0.4–2 mg | IV/IO/IM/IN/ET | not captured | standing | page 73 |
| Opioid overdose | peds | 0.1 mg/kg | IM/IN | not captured | standing | page 73 |
| Opioid overdose | peds | 0.1 mg/kg | IV/IO/IM/IN/ET | not captured | standing | page 73 |
Nicardipine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 2.5 mg | IV | not captured | standing | page 114 |
Nitroglycerin
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| ACS / chest pain | adult | 0.3 mg | SL | not captured | standing | page 75 |
| CHF / pulmonary edema | adult | 0.3 mg | SL | not captured | standing | page 77 |
| CHF / pulmonary edema | adult | 400 mcg | IV | not captured | standing | page 77 |
Norepinephrine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Hypotension / shock | peds | 0.1–2 mcg/kg | IV/IO | not captured | standing | page 112 |
Ondansetron
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Nausea / vomiting | adult | 4 mg | IV/IO/IM/PO/ODT | not captured | standing | page 11 |
| Nausea / vomiting | peds | 0.2 mg/kg | IV/IO/IM/PO/ODT | not captured | standing | page 11 |
Oxymetazoline
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 2 spray | IN | not captured | standing | page 22 |
Oxytocin
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Obstetric hemorrhage | adult | 10 unit | IM | not captured | standing | page 138 |
Piperacillin-Tazobactam
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Sepsis | adult | 3.375 g | IV | not captured | standing | page 34 |
| Trauma / hemorrhage | adult | 3.375 g | IV/IO | not captured | standing | page 125 |
Pralidoxime
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Nerve agent exposure | adult | 600 mg | IV/IO/IM | not captured | standing | page 181 |
| Nerve agent exposure | peds | 15–25 mg/kg | IV/IO/IM | not captured | standing | page 181 |
Prochlorperazine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Nausea / vomiting | adult | 5 mg | IV/IO/IM | not captured | standing | page 11 |
| Nausea / vomiting | peds | 2.5 mg | IV/IO/IM | not captured | standing | page 11 |
Promethazine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Nausea / vomiting | adult | 25 mg | IM | not captured | standing | page 12 |
Rocuronium
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| RSI induction | adult | 1 mg/kg | IV/IO | not captured | standing | page 50 |
| RSI induction | peds | 1 mg/kg | IV/IO | not captured | standing | page 50 |
Sodium Bicarbonate
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Hyperkalemia | adult | 100 mEq | IV/IO | not captured | standing | page 109 |
| Hyperkalemia | peds | 1 mEq/kg | IV/IO | not captured | standing | page 109 |
| Tricyclic overdose | adult | 100 mEq | IV/IO | not captured | standing | page 179 |
| Tricyclic overdose | peds | 1 mEq/kg | IV/IO | not captured | standing | page 179 |
Sodium Thiosulfate
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Cyanide poisoning | adult | 12.5 g | IV | not captured | standing | page 170 |
| Cyanide poisoning | peds | 1 mL/kg | IV | not captured | standing | page 170 |
Succinylcholine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| RSI induction | adult | 2 mg/kg | IV/IO | not captured | standing | page 50 |
| RSI induction | peds | 2 mg/kg | IV/IO | not captured | standing | page 50 |
Tenecteplase
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Stroke | adult | Weight-based | IV | not captured | standing | page 114 |
Terbutaline
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Respiratory distress | adult | 0.25 mg | IM/SQ | not captured | standing | page 52 |
| Respiratory distress | peds | 0.25 mg | IM/SQ | not captured | standing | page 52 |
Tetracaine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 2 drop | not captured | not captured | standing | page 185 |
| Other | peds | 2 drop | not captured | not captured | standing | page 185 |
Tranexamic Acid
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 1 g | TOP | not captured | standing | page 23 |
| Trauma / hemorrhage | adult | 1 g | TOP | not captured | standing | page 20 |
| Trauma / hemorrhage | adult | 1–2 g | IV | not captured | standing | page 129 |
| Trauma / hemorrhage | peds | 15 mg/kg | IV | not captured | standing | page 129 |
Vecuronium
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 10 mg | IV/IO | not captured | standing | page 93 |
Ziprasidone
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Agitation | adult | 20 mg | IM | not captured | standing | page 40 |
| Hyperactive delirium | adult | 20 mg | IM | not captured | standing | page 41 |